Latest Uganda News

Page 1 of 5
Island Pharmaceuticals is moving Galidesivir into a decisive sequence of Marburg animal studies after the FDA confirmed an Animal Rule pathway for the antiviral. The company also expects to generate prospective human data through an approved Uganda Ebola program, although approval, funding and commercial outcomes remain unresolved.
Victor Sage
Victor Sage
17 Nov 2026
eMetals has confirmed three scheelite-bearing skarn horizons in the first five holes of its maiden Utah tungsten drilling program, with assays still pending. The explorer also expanded its Mineral Range ground position to 145 claims while ending the quarter with A$1.541 million in cash.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Blaze Minerals has reported exceptionally high-grade tungsten channel samples from its Bahati Project in Uganda, while completing the $2.06 million second tranche of a larger placement after quarter end. The September quarter closed with just $184,000 in cash and an estimated 0.38 quarters of funding before that financing was received.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Island Pharmaceuticals has secured approvals to use Galidesivir in Uganda’s Bundibugyo Ebola outbreak while advancing two complementary Marburg studies and expanding manufacturing. The progress comes with a sharper funding question: cash fell to A$7.83 million after quarterly operating outflows of A$4.93 million, leaving an estimated 1.6 quarters of funding.
Victor Sage
Victor Sage
26 Oct 2026
Ionic Rare Earths has moved its Belfast magnet recycling project closer to construction while expanding into the United States through a proposed US$100 million joint venture. The progress comes with key funding, approvals and definitive agreements still outstanding.
Victor Sage
Victor Sage
13 Oct 2026
Island Pharmaceuticals has begun GMP production of Galidesivir, with the first 5kg batch targeted for an investigational Ebola treatment program in Uganda. A second batch is intended to support a pivotal Marburg animal study under the FDA’s Animal Rule pathway.
Victor Sage
Victor Sage
2 Oct 2026
Blaze Minerals reported a narrower FY2026 loss, but ended the year with just $43,552 in cash and an auditor-highlighted material uncertainty over its ability to continue as a going concern. The company is relying on shareholder-approved funding, a proposed 20:1 consolidation and a conditional Ugandan tungsten acquisition to reshape its next phase.
Maxwell Dee
Maxwell Dee
29 Sept 2026
eMetals has shifted its exploration focus from Uganda to a larger Utah tungsten project, where high-grade re-assays have set up a 17-hole drilling campaign. But the ASX-listed explorer ended the year with $1.79 million in cash, $1.40 million of deferred consideration and an auditor-highlighted material uncertainty over its ability to continue as a going concern.
Maxwell Dee
Maxwell Dee
29 Sept 2026
Ionic Rare Earths is pushing toward commercial magnet recycling in Belfast and the United States, but its FY2026 report flags a material uncertainty over its ability to continue as a going concern. The company reported a larger A$14.9 million loss and A$13.9 million in operating cash outflows, despite government support and new strategic partnerships.
Victor Sage
Victor Sage
17 Sept 2026
Blaze Minerals has struck a binding deal to acquire a majority interest in two historically rich tungsten projects in Uganda, backed by a $2.25 million capital raise to fund exploration and acquisition costs.
Maxwell Dee
Maxwell Dee
3 Sept 2026
Island Pharmaceuticals has commissioned a second manufacturing run of its antiviral Galidesivir, aiming to stockpile up to 800 treatment courses by late 2026 to support rapid response to the fast-spreading Bundibugyo Ebola outbreak and biodefence efforts.
Victor Sage
Victor Sage
21 Aug 2026
Ionic Rare Earths (ASX: IXR) has secured $8 million through a placement to back its Belfast Plant commercialisation and US growth plans, supported by a mix of domestic and international investors including a strategic US partner.
Maxwell Dee
Maxwell Dee
5 Aug 2026

Browse the archive

Full archive